Marcadores metabólicos preoperatorios como factor en la estancia postquirúrgica del Hospital Abel Gilbert Pontón 2022-2024.

Abstract

Metabolic biomarkers, which hold great clinical value as tools for assessing risk factors associated with the development of cardiovascular diseases and other non-communicable chronic conditions, have the potential to be used in estimating postoperative recovery and hospital stay for patients. Proper healing of surgical wounds and infection prevention are processes largely dependent on the state of the immune system. In this context, it has been observed that patients presenting unfavorable metabolic conditions, such as obesity or metabolic syndrome, tend to experience prolonged hospital stays following surgical procedures. A prolonged hospital stay not only increases the risk of complications but it also correlates with the incidence of adverse events related to surgical intervention. Additionally, the care of these patients is further complicated by various factors that limit their recovery, such as difficult transportation, dimensional restrictions of medical equipment and instruments, as well as reduced mobility and poor blood perfusion; factors which hinder the healing of injuries of any nature. Therefore, the analysis of preoperative metabolic biomarkers could provide necessary information to optimize clinical management and improve postoperative outcomes, thus constituting a comprehensive approach to healthcare that warrants further investigation.